Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
130 JPY
4.55 B JPY
102.89 B JPY
17.79 M
About MOCHIDA PHARMACEUTICAL CO
Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. It operates through following business divisions: Pharmaceuticals and Healthcare Products. The Pharmaceuticals division conducts research and development for medical needs. The Healthcare Products division manufactures and sells cosmetic and medicated products. It also manufactures and sells prescription drugs for cardiovascular, obstetrics and gynecology, dermatology, emergency and psychiatric ailments. The company was founded by Ryokichi Mochida in February 1913 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4534 is 3,535 JPY — it has increased by 1.65% in the past 24 hours. Watch MOCHIDA PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange MOCHIDA PHARMACEUTICAL CO stocks are traded under the ticker 4534.
4534 stock has risen by 1.50% compared to the previous week, the month change is a −1.60% fall, over the last year MOCHIDA PHARMACEUTICAL CO has showed a 5.05% increase.
4534 reached its all-time high on Mar 8, 2019 with the price of 6,110 JPY, and its all-time low was 1,190 JPY and was reached on Nov 19, 2002. View more price dynamics on 4534 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4534 stock is 4.41% volatile and has beta coefficient of 0.49. Track MOCHIDA PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is MOCHIDA PHARMACEUTICAL CO there?
Today MOCHIDA PHARMACEUTICAL CO has the market capitalization of 120.00 B, it has decreased by −0.30% over the last week.
Yes, you can track MOCHIDA PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
MOCHIDA PHARMACEUTICAL CO is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
4534 net income for the last quarter is 1.27 B JPY, while the quarter before that showed 1.55 B JPY of net income which accounts for −18.21% change. Track more MOCHIDA PHARMACEUTICAL CO financial stats to get the full picture.
MOCHIDA PHARMACEUTICAL CO dividend yield was 2.48% in 2023, and payout ratio reached 63.10%. The year before the numbers were 2.40% and 44.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 3, 2024, the company has 1.52 K employees. See our rating of the largest employees — is MOCHIDA PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOCHIDA PHARMACEUTICAL CO EBITDA is 8.54 B JPY, and current EBITDA margin is 8.37%. See more stats in MOCHIDA PHARMACEUTICAL CO financial statements.
Like other stocks, 4534 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOCHIDA PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOCHIDA PHARMACEUTICAL CO technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOCHIDA PHARMACEUTICAL CO stock shows the strong buy signal. See more of MOCHIDA PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.